Forward Management LLC increased its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 0.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,909 shares of the company’s stock after purchasing an additional 10 shares during the quarter. Forward Management LLC’s holdings in Johnson & Johnson were worth $1,311,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in JNJ. Lenox Wealth Advisors Inc. grew its holdings in Johnson & Johnson by 0.6% during the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson by 0.4% during the 1st quarter. Lbmc Investment Advisors LLC now owns 3,704 shares of the company’s stock valued at $461,000 after buying an additional 14 shares in the last quarter. Stratford Consulting LLC grew its holdings in Johnson & Johnson by 0.6% during the 2nd quarter. Stratford Consulting LLC now owns 2,728 shares of the company’s stock valued at $361,000 after buying an additional 16 shares in the last quarter. Iron Financial LLC grew its holdings in Johnson & Johnson by 0.5% during the 2nd quarter. Iron Financial LLC now owns 3,782 shares of the company’s stock valued at $500,000 after buying an additional 19 shares in the last quarter. Finally, North Point Portfolio Managers Corp OH grew its holdings in Johnson & Johnson by 0.7% during the 2nd quarter. North Point Portfolio Managers Corp OH now owns 2,923 shares of the company’s stock valued at $387,000 after buying an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 65.61% of the company’s stock.

Several equities analysts have weighed in on JNJ shares. Cowen and Company restated an “outperform” rating and set a $155.00 price target (up previously from $147.00) on shares of Johnson & Johnson in a report on Wednesday, October 18th. UBS AG restated a “buy” rating and set a $148.00 price target on shares of Johnson & Johnson in a report on Thursday, August 31st. Jefferies Group LLC raised their price target on Johnson & Johnson from $157.00 to $160.00 and gave the company a “buy” rating in a report on Monday, October 16th. Zacks Investment Research upgraded Johnson & Johnson from a “sell” rating to a “hold” rating in a report on Wednesday, October 4th. Finally, Credit Suisse Group set a $154.00 price target on Johnson & Johnson and gave the company an “outperform” rating in a report on Thursday, October 19th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $143.70.

Shares of Johnson & Johnson (NYSE JNJ) opened at $137.29 on Thursday. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $371,653.16, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 2.81 and a beta of 0.82. Johnson & Johnson has a 1 year low of $109.32 and a 1 year high of $144.35.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.80 by $0.10. The business had revenue of $19.65 billion during the quarter, compared to analyst estimates of $19.29 billion. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. Johnson & Johnson’s revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.68 EPS. equities research analysts predict that Johnson & Johnson will post 7.28 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Tuesday, November 28th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.45%. The ex-dividend date is Monday, November 27th. Johnson & Johnson’s payout ratio is 58.33%.

TRADEMARK VIOLATION NOTICE: This story was first reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/johnson-johnson-jnj-shares-bought-by-forward-management-llc/1720867.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.